Acute Myeloid Leukemia
Elevated AFlq gene expression is an independent adverse prognostic factor in AML
Published in Hematology Week, February 21st, 2005
According to recent research from the United States, "The AF1q gene, a mixed-lineage leukemia fusion partner, is highly expressed in hematopoietic progenitor cells but has low expression in differentiated cells.
"We determined the expression of the AF1q gene by reverse transcriptase-polymerase chain reaction in 64 pediatric acute myeloid leukemia (AML) patients treated on Children's Cancer Group clinical trial CCG-2891 and correlated its expression level to clinical characteristics and outcome."
"AF1q expression in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2005-02-21)
More Articles from Hematology Week
- Anti-Inflammatory Therapy
Modulation of iron metabolism a potential approach for anti-inflammatory therapy - Antioxidants
Reactive oxygen species mediate RANK signaling in osteoclasts - Colorectal Cancer
Functional polymorphism in E-cadherin gene associated with colorectal cancer - Resveratrol
Toxicity from resveratrol seen only at the highest dose tested - Stomach Cancer
COX-2 overexpression may contribute to carcinogenesis - Acute Myeloid Leukemia
MNK1 is target of several leukemogenic fusion proteins - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
